CA9 and neoplasm: Selective inhibition of CA IX/XII disrupts the acidic pH gradient essential for tumor survival, leading to impaired proliferation and increased sensitivity to other anticancer agents while sparing normal tissues (Neri and Supuran, 2011; Lou et al., 2011).